Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
01 6Polpharma
02 3Dr. Reddy's Laboratories
03 5Pharmathen SA
04 82care4
05 16Abacus Medicine
06 4Actavis Inc
07 8Ajanta Pharma Limited
08 4Alembic Pharmaceuticals Limited
09 5Amdipharm Mercury Company Limited
10 4Amneal Pharmaceuticals
11 4CSPC Pharmaceutical Group
12 3Centocor
13 5Ebb Medical
14 12Exeltis
15 6Genericon Pharma Ges.M.B.H.
16 4Helsinn Advanced Synthesis
17 6Heumann
18 8Inventia Healthcare Limited
19 56Janssen-Cilag
20 30Johnson & Johnson Innovative Medicine
21 6Krka
22 5Laboratorios Liconsa
23 4Lupin Ltd
24 3Medartuum
25 8Mepha Pharma
26 6Neuraxpharm
27 8ORIFARM GROUP AS
28 3Pantson Pharma Pvt. Limited
29 2RELIANCE FORMULATION PVT. LTD
30 4RK Pharma
31 12STADA Arzneimittel
32 18Sandoz B2B
33 5Spirig Healthcare
34 4Sun Pharmaceutical Industries Limited
35 9Teva Pharmaceutical Industries
36 6Uab Bijon Medica
37 4Unichem Laboratories Limited
38 12Viatris
39 11Zentiva
40 4Zydus Pharmaceuticals
41 16Blank
01 8Depot injection fluid, suspension
02 20ER Tablet
03 10Extended Release Tablet
04 9Extended Release Tablets
05 4INJ
06 90Injectable Solution
07 3LP Tablet
08 6Modified Release Tablet
09 1Paliperidone 100Mg 1 Unit Parenteral Use Rp
10 1Paliperidone 150Mg 1 Unit Parenteral Use Rp
11 1Paliperidone 3Mg 28 Combined Oral Use Rp
12 1Paliperidone 50Mg 1 Unit Parenteral Use Rp
13 1Paliperidone 6Mg 28 Combined Oral Use Rp
14 1Paliperidone 75Mg 1 Unit Parenteral Use Rp
15 1Paliperidone 9Mg 28 Combined Oral Use Rp
16 8Prolonged Release Tablet
17 91Suspension For Injection
18 3TAB
19 3TABLET (EXTENDED-RELEASE)
20 4TABLET, EXTENDED RELEASE; ORAL
21 52TABLET, EXTENDED RELEASE;ORAL
22 15Tablet
23 14Blank
01 28Allowed
02 158Approved
03 4Countries Registered In: US (Filed 2012)
04 9DISCN
05 19Deregistered
06 4Generic
07 7Originator
08 43RX
09 12Registered in US
10 4US (Filed 2012)
11 59Blank
01 2Byannli
02 6Dnepr
03 16INVEGA
04 14Invega
05 1Invega 3Mg
06 1Invega 6Mg
07 1Invega 9Mg
08 2Invega Hafyera
09 5Invega Sustenna
10 4Invega Trinza
11 5Mopetia
12 6Niapelf
13 1PALICALM ER 3
14 1PALICALM ER 6
15 3PALIPERIDON KRKA
16 47PALIPERIDONE
17 3PALIPERIDONE SANDOZ
18 3PALIPERIDONE TEVA
19 6Paliperidon Heumann
20 3Paliperidon Krka
21 35Paliperidon Teva
22 6Paliperidon Zentiva
23 4Paliperidone 2Care4
24 6Paliperidone Bijon
25 3Paliperidone Ebb
26 6Paliperidone Exeltis
27 6Paliperidone Genericon
28 6Paliperidone Janssen
29 6Paliperidone Janssen-Cilag International
30 5Paliperidone Liconsa
31 9Paliperidone Sandoz
32 1Paliperidone Spirig HC retard
33 4Paliperidone Spirig HC retard
34 6Paliperidone Stada
35 6Paliperidone Viatris
36 6Paliperidone Viatris Pharma
37 1Paliperidone-Mepha
38 4Paliperidone-Mepha im
39 3Paliperidone-Mepha retard
40 9Palmeux
41 6Poltraxin
42 6Pratyria
43 6Psylipax
44 8Trevicta
45 4Trevicta
46 1XEPLION 100 mg/1,0 ml
47 1XEPLION 150 mg/1,50 ml
48 1XEPLION 50 mg/0,50 ml
49 1XEPLION 75 mg/0,75 ml
50 19Xeplion
51 32Blank
01 14Australia
02 3Canada
03 5Greece
04 25India
05 20Italy
06 8Norway
07 7South Africa
08 177Sweden
09 28Switzerland
10 56USA
11 4Blank
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Poltraxin
Dosage Form : Suspension For Injection
Dosage Strength : 100mg
Packaging :
Approval Date : 04/07/2025
Application Number : 20221101000179
Regulatory Info : Approved
Registration Country : Sweden
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : PALIPERIDONE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 3MG
Packaging :
Approval Date : 2025-02-19
Application Number : 205559
Regulatory Info : RX
Registration Country : USA
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 1.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Poltraxin
Dosage Form : Suspension For Injection
Dosage Strength : 100mg, 150mg
Packaging :
Approval Date : 04/07/2025
Application Number : 20230216000134
Regulatory Info : Approved
Registration Country : Sweden
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Poltraxin
Dosage Form : Suspension For Injection
Dosage Strength : 150mg
Packaging :
Approval Date : 04/07/2025
Application Number : 20221101000186
Regulatory Info : Approved
Registration Country : Sweden
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Poltraxin
Dosage Form : Suspension For Injection
Dosage Strength : 25mg
Packaging :
Approval Date : 04/07/2025
Application Number : 20221101000148
Regulatory Info : Approved
Registration Country : Sweden
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Poltraxin
Dosage Form : Suspension For Injection
Dosage Strength : 50mg
Packaging :
Approval Date : 04/07/2025
Application Number : 20221101000155
Regulatory Info : Approved
Registration Country : Sweden
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Poltraxin
Dosage Form : Suspension For Injection
Dosage Strength : 75mg
Packaging :
Approval Date : 04/07/2025
Application Number : 20221101000162
Regulatory Info : Approved
Registration Country : Sweden
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : PALIPERIDONE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 6MG
Packaging :
Approval Date : 2025-02-19
Application Number : 205559
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : PALIPERIDONE
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 9MG
Packaging :
Approval Date : 2025-02-19
Application Number : 205559
Regulatory Info : RX
Registration Country : USA
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 3MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 6MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 9MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Pharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.
Regulatory Info :
Registration Country : Greece
Brand Name :
Dosage Form : Prolonged Release Tablet
Dosage Strength : 12MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Greece
Regulatory Info : RX
Registration Country : USA
Brand Name : INVEGA
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 3MG
Packaging :
Approval Date : 2006-12-19
Application Number : 21999
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : INVEGA
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 6MG
Packaging :
Approval Date : 2006-12-19
Application Number : 21999
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : INVEGA
Dosage Form : TABLET, EXTENDED RELEASE;ORAL
Dosage Strength : 9MG
Packaging :
Approval Date : 2006-12-19
Application Number : 21999
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Paliperidone Stada
Dosage Form : Suspension For Injection
Dosage Strength : 25mg
Packaging :
Approval Date : 18/04/2024
Application Number : 20221221000028
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Paliperidone Stada
Dosage Form : Suspension For Injection
Dosage Strength : 50mg
Packaging :
Approval Date : 18/04/2024
Application Number : 20221221000035
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Paliperidone Stada
Dosage Form : Suspension For Injection
Dosage Strength : 75mg
Packaging :
Approval Date : 18/04/2024
Application Number : 20221221000042
Regulatory Info : Approved
Registration Country : Sweden
